Form 4: Ventas CEO Debra Cafaro Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4
Debra Cafaro, CEO of Ventas, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan, while also making a charitable donation of shares.
Summary
- Debra A. Cafaro, Chairman and CEO of Ventas, Inc., reported transactions involving the company's common stock.
- On February 28, 2025, Cafaro exercised 41,294 stock options at a price of $63.24 and sold the resulting shares at a weighted average price of $69.076, ranging from $69.00 to $69.24.
- On March 3, 2025, she exercised 388 stock options at $62.22 and sold the shares at $71.
- On March 3, 2025, Cafaro gifted 10,000 shares to a charitable organization.
- On March 4, 2025, she exercised 1,200 stock options at $62.22 and sold the shares at $71.04.
- These transactions were executed under a Rule 10b5-1 trading plan established on March 28, 2024.
- Following these transactions, Cafaro directly owns 1,128,143 shares of Ventas common stock and holds unexercised options for 777,448 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment. The transactions are part of a pre-planned strategy, and there's no indication of unusual activity or concern. The charitable donation is a slightly positive factor.
Positives
- The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which can mitigate concerns about insider trading.
- A charitable donation of 10,000 shares was made, which could be viewed positively.
Risks
- While the transactions are under a 10b5-1 plan, large sales by a CEO could be perceived negatively by some investors.
Industry Context
Insider transactions are common and closely watched, especially in REITs like Ventas. The use of a 10b5-1 plan is a standard practice to avoid accusations of trading on inside information.
Comparison to Industry Standards
- Comparing Cafaro's transactions to other REIT CEOs' Form 4 filings would provide context on the scale and frequency of her stock activity.
- Reviewing Ventas' stock performance relative to peers like Welltower (WELL) and Healthpeak Properties (PEAK) around these transaction dates could reveal market sentiment.
- Analyzing the terms of Cafaro's stock option grants against industry benchmarks for executive compensation in similar-sized REITs would offer further insight.
Stakeholder Impact
- The transactions could have a minor impact on shareholders due to the change in ownership, but the 10b5-1 plan mitigates concerns.
- Employees may be indirectly affected by market perceptions of executive stock activity.
Key Dates
| Date | Description |
|---|---|
| 11/02/2016 | Original grant date of some stock options exercised |
| 01/18/2017 | Original grant date of some stock options exercised |
| 03/28/2024 | Date the Rule 10b5-1 trading plan was entered into |
| 02/28/2025 | Date of first reported transaction (option exercise and sale) |
| 03/03/2025 | Date of gift and additional option exercise and sale |
| 03/04/2025 | Date of additional option exercise and sale |
| 11/02/2026 | Expiration date of some stock options |
| 01/18/2027 | Expiration date of some stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.